Modulation of inflammatory peritoneal cell function and metabolism by methotrexate

Area of Science:

• Immunology
• Pharmacology
• Cell Biology

Background:

• Methotrexate (MTX) is a cornerstone of cancer chemotherapy.
• Its precise impact on cellular antitumor defense mechanisms remains incompletely understood.
• Investigating MTX's effects on the inflammatory response is crucial for understanding its broader biological activity.

Purpose of the Study:

• To evaluate the effect of Methotrexate (MTX) on the cellular inflammatory response in vivo and in vitro.
• To determine if MTX perturbs the metabolic functions of inflammatory cells.

Main Methods:

• Male Sprague-Dawley rats received daily intraperitoneal injections of MTX or a control vehicle.
• Peritoneal exudate cells were collected 96 hours post-stimulus.
• In vitro assays assessed glucose oxidation and protein synthesis in peritoneal exudate cells exposed to varying MTX concentrations.

Main Results:

• MTX treatment (1.2 mg/kg/day) significantly reduced the number of peritoneal exudate cells, particularly macrophages.
• In vitro, MTX (10(-3)M) significantly depressed glucose oxidation by peritoneal exudate cells.
• Protein synthesis was inhibited at 4 x 10(-3)M MTX, without affecting cell viability.

Conclusions:

• Therapeutic concentrations of MTX can decrease macrophage recruitment to inflammatory sites.
• MTX diminishes energy metabolism and protein synthesis in inflammatory cells.
• These findings suggest MTX may modulate cellular antitumor defenses through effects on inflammatory cell function.